Attention deficit hyperactivity disorder comorbidity in an adolescent diagnosed with L-2 hydroxyglutaric aciduria and response to atomoxetine treatment: a case report
Author(s) -
Çiğdem Yektaş,
Ali Evren Tufan
Publication year - 2016
Publication title -
dusunen adam the journal of psychiatry and neurological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.205
H-Index - 12
ISSN - 1018-8681
DOI - 10.5350/dajpn2016290309
Subject(s) - atomoxetine , attention deficit hyperactivity disorder , ataxia , medicine , comorbidity , pediatrics , psychiatry , epilepsy , methylphenidate , psychology
L-2-hydroxyglutaric aciduria (L-2 HGA) is a rare, neurodegenerative, slowly progressing and autosomal recessively inherited metabolic disorder. The disease progresses with mental retardation, behavioral disorder, ataxia, extrapyramidal signs and epileptic seizures. Diagnosis is made by detection of increased levels of L-2-hydroxyglutaric acid in urine, plasma or cerebrospinal fluid. In this report, we presented a 13 year old male patient diagnosed with L-2 HGA and had seizures, intellectual disability, attention deficit hyperactivity disorder (ADHD) symptoms and failure in school performance. Here we discussed this rare disease with ADHD symptoms and the response to atomoxetine treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom